ADHD in Focus

ADHD: Rising Diagnoses, Persistent Underdiagnosis, and Continuing Conceptual Debates

Diagnoses of Attention-Deficit/Hyperactivity Disorder (ADHD) have increased substantially in recent years, particularly among adolescents and adults. This increase has generated considerable public and academic debate regarding whether ADHD is being increasingly recognised, overdiagnosed, or whether substantial unmet need remains. Current evidence suggests that, despite rising referral and diagnosis rates, ADHD, as it’s currently defined, may remain significantly underdiagnosed in the United Kingdom.

Recent population-based research from England found that recorded ADHD prevalence has increased markedly, particularly since 2020. However, diagnosis rates remain substantially below estimates derived from epidemiological studies, suggesting that many individuals with ADHD continue to remain unidentified within healthcare systems (John et al., 2026). These findings create an apparent paradox: ADHD diagnoses are rising rapidly, yet large numbers of people who may meet diagnostic criteria still appear not to receive assessment, diagnosis, or support.

ADHD is classified as a neurodevelopmental condition characterised by persistent patterns of inattention and/or hyperactivity-impulsivity that interfere with functioning or development. Current diagnostic systems require symptoms to have been present during childhood, even when diagnosis occurs much later in life. Furthermore, symptoms must result in clinically significant impairment across multiple domains, such as education, employment, relationships, or everyday functioning. Diagnosis is therefore based not merely on the presence of ADHD traits but on their severity, persistence, and impact.

ADHD as a Dimensional Condition

One reason ADHD remains conceptually controversial is that attentional capacity, impulsivity, activity levels, and self-regulation exist on a continuum throughout the population rather than as clearly distinct categories.

Difficulties with concentration, organisation, procrastination, forgetfulness, and impulse control are universal human experiences to some degree. As a result, distinguishing between normal variation and clinically significant disorder is inherently complex.

This dimensional perspective has led many researchers to argue that ADHD represents the extreme end of traits distributed throughout the population rather than a wholly distinct condition. Such arguments do not necessarily challenge the validity of ADHD as a diagnosis; instead, they highlight the difficulties involved in establishing diagnostic thresholds. Consequently, clinical judgement remains an essential component of assessment alongside formal diagnostic criteria.

Rising Diagnoses and Persistent Underdiagnosis

Research consistently demonstrates substantial increases in ADHD diagnosis rates. In England, prevalence recorded within healthcare systems has risen considerably in recent years, particularly among adolescents and young adults (John et al., 2026). However, epidemiological estimates continue to exceed recorded prevalence figures. This discrepancy suggests that substantial underdiagnosis may persist despite increased public awareness and growing referral rates.

Particular concerns have been raised regarding historically under-recognised groups, including:

• Women and girls

• Older adults

• Individuals with predominantly inattentive presentations

• People who have developed compensatory coping strategies

• Individuals whose symptoms have been attributed to anxiety, depression, trauma, or personality characteristics

Gender has become an especially important area of research. Historically, ADHD was primarily studied in boys displaying overt hyperactivity. Girls and women are more likely to present with inattentive symptoms, internalising difficulties, and masking strategies that may make recognition less likely. Greater awareness of these differences has contributed to increasing diagnoses among females in recent years.

International comparisons further illustrate the complexity of interpreting diagnosis rates. In the United States, approximately 8.4% of children and adolescents aged 2-17 years were reported to have received an ADHD diagnosis in 2016. Historically, UK diagnosis rates have been considerably lower. More recent English data suggest recorded prevalence has risen to approximately 2% overall, with substantially higher rates among younger age groups, yet still below expected prevalence estimates. Such disparities continue to fuel debate regarding both under-recognition and potential overdiagnosis.

In the UK, concerns about underdiagnosis have also become intertwined with service provision. Long waiting lists for specialist assessment, regional variation in access to services, and growing demand have become significant challenges for healthcare systems, potentially contributing to delayed diagnosis and treatment.

Comorbidity and Diagnostic Complexity

ADHD rarely occurs in isolation. High rates of comorbidity contribute substantially to both diagnostic complexity and under-recognition.

Common co-occurring conditions include:

• Anxiety disorders

• Depressive disorders

• Autism spectrum conditions

• Sleep disorders

• Substance use disorders

• Specific learning difficulties

  
  

In some cases, ADHD symptoms may be mistaken for manifestations of these conditions. Conversely, ADHD itself may remain undetected while treatment focuses on secondary difficulties such as anxiety or depression. This overlap further complicates attempts to estimate the true prevalence of ADHD.

The Value of Diagnosis

A growing body of research suggests that receiving an ADHD diagnosis in adulthood can confer substantial benefits. Adults who receive an appropriate diagnosis frequently report improved self-understanding, reduced self-blame, enhanced access to support, and improved occupational and social functioning. Longitudinal evidence suggests that diagnosis may facilitate positive changes in self-esteem and quality of life through access to treatment, psychoeducation, and appropriate accommodations (Nylander et al., 2021).

For many adults, diagnosis provides a framework through which lifelong difficulties can be understood, not as evidence of laziness or personal failure, but as manifestations of an underlying neurodevelopmental condition.

Treatment Approaches

Pharmacological interventions remain among the most extensively researched treatments for ADHD. Stimulant medications, particularly methylphenidate and amphetamine-based preparations, are considered first-line treatments in many countries and have been associated with improvements in attention, executive functioning, and everyday functioning. Emerging evidence also suggests beneficial effects on quality of life and self-esteem among adults receiving treatment (Di Lorenzo et al., 2026).

Non-pharmacological interventions may also provide important benefits, particularly when used alongside medication. These include:

• Cognitive Behavioural Therapy (CBT)

• Psychoeducation

• Organisational skills training

• ADHD coaching

• Mindfulness-based approaches

Recent meta-analytic evidence suggests CBT can improve functioning and quality of life among adults diagnosed with ADHD (López-Pinar et al., 2026).

Medicalisation and Diagnostic Expansion

Not all researchers interpret rising diagnosis rates exclusively as evidence of improved recognition. Conrad and colleagues have argued that broader social processes may contribute to increasing rates of diagnosis. Proposed influences include diagnostic expansion, pharmaceutical marketing, growing media attention, changing educational expectations, and evolving cultural understandings of mental health (Conrad, 2014; Conrad & Bergey, 2014). Importantly, this perspective does not necessarily deny the existence or legitimacy of ADHD. Rather, it encourages critical examination of how societies define, interpret, and medicalise behavioural variation.

The challenge lies in distinguishing between inappropriate medicalisation of normal human differences and the identification of genuine unmet clinical need.

Neurodiversity Perspectives

Alongside medical and psychiatric models, growing attention has been directed towards neurodiversity perspectives. The neurodiversity movement argues that neurological differences, including ADHD, autism, and dyslexia, should not be viewed solely through a deficit-based framework. From this perspective, ADHD may represent a naturally occurring variation in human cognition associated with both challenges and potential strengths.

Advocates often emphasise characteristics such as creativity, curiosity, divergent thinking, energy, enthusiasm, and innovative problem-solving. However, most researchers also acknowledge that ADHD can produce substantial impairment and distress. Contemporary discussions increasingly focus on balancing recognition of strengths with acknowledgement of genuine difficulties.

Rather than replacing medical models, neurodiversity perspectives are increasingly viewed as complementary frameworks that encourage greater attention to environmental adaptation and social inclusion.

The Search for More Objective Diagnosis

Estimating the true prevalence of ADHD remains challenging because there is currently no objective biological marker capable of reliably confirming diagnosis. Unlike what might be termed physical health conditions, that may be identified through blood tests, imaging, or genetic screening, ADHD diagnosis relies primarily on:

• Clinical interviews

• Developmental history

• Symptom rating scales

• Reports from family members, schools, or employers

• Assessments of functional impairment

Consequently, prevalence estimates depend heavily on diagnostic criteria and assessment methods.

Researchers continue to investigate approaches that may improve diagnostic accuracy. Promising areas include:

Motion-Capture Technologies

Systems capable of objectively quantifying head movement patterns and activity levels.

Electroencephalography (EEG)

Studies have reported differences in patterns of brain activity among individuals with ADHD, including evidence of elevated theta-to-beta wave ratios in some populations.

Computerised Attention and Impulse-Control Tasks

Objective assessments of sustained attention, response inhibition, and impulsivity.

Chronoception / Time Perception

Difficulties estimating, managing, and monitoring time appear common among many people with ADHD and are increasingly being investigated as a potentially important characteristic.

Emotional Regulation Assessment

Emotional dysregulation is receiving growing attention as an important feature of ADHD despite not being central within current diagnostic criteria.

At present, these approaches may only complement rather than replace clinical assessment.

ADHD and the Evolutionary Mismatch Hypothesis

An increasingly influential perspective proposes that some characteristics associated with ADHD may be understood through an evolutionary lens. The evolutionary mismatch hypothesis suggests that traits such as heightened responsiveness to novel stimuli, increased exploratory behaviour, rapid attentional shifting, elevated activity levels, and greater environmental vigilance may have conferred adaptive advantages within ancestral hunter-gatherer environments (Jensen et al., 1997; Williams & Taylor, 2006).

In contemporary societies, however, success often depends on sustained concentration, prolonged sedentary activity, organisation, routine administration, and delayed gratification. Formal education systems, in particular, require children to spend long periods engaged in highly structured, relatively low-stimulation activities.

From this perspective, some difficulties associated with ADHD may arise partly from a mismatch between evolved cognitive tendencies and modern environmental demands. However, this explanation remains debated and ADHD is associated with significant impairment across diverse cultural contexts and societal structures, suggesting that environmental mismatch alone cannot fully explain the condition. Most researchers therefore regard evolutionary explanations as one potentially useful framework among several rather than a definitive account of ADHD's origins (Del Giudice et al., 2010).

Beyond "Attention Deficit": Emerging Conceptualisations of ADHD

Contemporary thinking increasingly challenges the notion that ADHD is best understood as a simple deficit of attention. Many individuals with ADHD are capable of sustaining intense concentration when engaged with activities they find intrinsically rewarding, stimulating, or meaningful. This phenomenon, often referred to as hyperfocus, appears inconsistent with a straightforward account of impaired attention. Consequently, growing numbers of researchers have argued that ADHD may be more accurately conceptualised as a condition involving difficulties regulating attention rather than an inability to pay attention.

Emerging models place greater emphasis on:

• Executive functioning

• Motivation and reward processing

• Self-regulation

• Emotional regulation

• Cognitive flexibility

• Time management

From this perspective, ADHD involves differences in when, where, and how attention is allocated rather than a simple reduction in attentional capacity.

Although no consensus currently exists regarding changes in nomenclature, these debates reflect broader shifts in scientific understanding.

Conclusion

ADHD remains one of the most extensively researched yet conceptually debated neurodevelopmental conditions. While diagnosis rates have increased substantially, evidence continues to suggest that significant under-recognition likely persists, particularly among women, older adults, and individuals whose presentation differs from traditional stereotypes.

At the same time, debates concerning diagnostic thresholds, dimensional models of psychopathology, medicalisation, neurodiversity, and evolutionary explanations demonstrate that scientific understanding of ADHD remains dynamic. Future advances in objective assessment may improve diagnostic precision, but it is increasingly apparent that ADHD cannot be reduced to a simple deficit of attention.

Instead, contemporary evidence suggests ADHD is best understood as a complex condition involving attention regulation, executive functioning, motivation, emotional regulation, and self-management. As research continues to develop, so too will our understanding of how best to conceptualise, assess, and support individuals living with ADHD.

Key Takeaways

ADHD diagnoses have increased substantially, particularly among adolescents and adults. Despite rising diagnosis rates, evidence suggests ADHD remains underdiagnosed in the UK.

Diagnosis requires clinically significant impairment, not merely the presence of ADHD traits.

ADHD traits appear to exist on a continuum, making diagnostic thresholds inherently complex.

Women and girls have historically been under-recognised due to differing symptom presentations.

ADHD frequently co-occurs with other mental health and neurodevelopmental conditions.

There is currently no objective biological test being used to confirm ADHD diagnosis. However, research into EEG, movement analysis, chronoception, emotional regulation, and digital assessment tools may improve future diagnostic accuracy.

Neurodiversity perspectives encourage recognition of both the challenges and strengths associated with ADHD.

Some researchers argue ADHD may partly reflect an evolutionary mismatch between ancestral human environments and modern educational and occupational demands.

Increasingly, ADHD is being conceptualised as a condition involving the regulation of attention rather than a simple attention deficit.

References

Conrad, P. (2014). The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders. Johns Hopkins University Press.

Conrad, P., & Bergey, M. (2014). The impending globalization of ADHD: Notes on the expansion and growth of a medicalized disorder. Social Science & Medicine, 122, 31-43.

Del Giudice, M., Ellis, B. J., & Shirtcliff, E. A. (2010). The Adaptive Calibration Model of stress responsivity. Neuroscience & Biobehavioral Reviews, 35(7), 1562-1592.

Di Lorenzo, R., et al. (2026). Effects of atomoxetine and methylphenidate on quality of life and self-esteem in adults with ADHD. Frontiers in Psychiatry, 17.

Jensen, P. S., Mrazek, D., Knapp, P. K., et al. (1997). Evolution and revolution in child psychiatry: ADHD as a disorder of adaptation. Journal of the American Academy of Child & Adolescent Psychiatry, 36(12), 1672-1679.

John, A., Stewart, G. R., Mandy, W., et al. (2026). Attention-Deficit/Hyperactivity Disorder in Children and Adults in England, 2000-2025: Recorded prevalence and diagnostic trends in a population-based observational study. The Lancet Regional Health - Europe, 67, 101740.

López-Pinar, C., et al. (2026). Cognitive behavioral therapy effects on global functioning, domain-specific functioning, and quality of life in adult ADHD: A comprehensive meta-analysis. Behaviour Research and Therapy, 201, 105026.

McKechnie, D., et al. (2023). Trends in ADHD Diagnosis and Prescribing in UK Primary Care. NIHR-funded research summary.

NHS England. (2025). ADHD Management Information: November 2025.

Nylander, E., Floros, O., Sparding, T., et al. (2021). Five-year outcomes of ADHD diagnosed in adulthood. Scandinavian Journal of Psychology, 62(1), 13-24.

Wakelin, C., Willemse, M., & Munnik, E. (2023). A review of recent treatments for adults living with attention-deficit/hyperactivity disorder. South African Journal of Psychiatry, 29.